Previous 10 | Next 10 |
Collaboration combines novel in vitro experimental methods and mechanistic modeling to accelerate development of orally inhaled drug products (OIDPs) and propose alternative approaches for bioequivalence Simulations Plus, Inc . (Nasdaq: SLP), a leading provider of mo...
The following slide deck was published by Simulations Plus, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Simulations Plus, Inc. 2022 Q4 - Results - Earnings Call Presentation
Simulations Plus, Inc. (SLP) Q4 2022 Earnings Conference Call October 26, 2022 5:00 PM ET Company Participants Brian Siegel – Hayden IR Shawn O’Connor – Chief Executive Officer Will Frederick – Chief Financial Officer Conference ...
Simulations Plus press release ( NASDAQ: SLP ): Q4 GAAP EPS of $0.05 misses by $0.01 . Revenue of $11.7M (+18.9% Y/Y) beats by $0.77M . Software revenue increased 10% to $5.9 million, representing 50% of total revenue; Services revenue increased 30% to $5.8...
Fiscal 2022 revenue increased 16% year-over-year to $53.9 million Diluted earnings per share increased 28% year-over-year to $0.60 Provides Fiscal 2023 guidance for total revenue of $59.3 million to $62.0 million (+10% to 15%) Simulations Plus, Inc. (Nasdaq: SLP)...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While several stocks under $50 to buy exist in the equities sector, which ones are worthwhile to hold onto forever? Identifying these picks in an unenviable task. However, given the worrying backdrop of the global economy, ...
New update expands the library of virtual populations and enhances connections between software platforms Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announce...
Conference call to be on Wednesday, October 26, 2022, at 5:00 PM ET Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2022, the period ended August 31, 2022, after the close of the...
Presentation Times and Weblinks Released for Over 100 Presenting Companies Wednesday and Thursday, September 21-22, 2022 NEW YORK, NY / ACCESSWIRE / September 20, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day September Small-...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn O’Connor will be presenting at the Sidoti Fall Small Cap Investor Conference taking...
News, Short Squeeze, Breakout and More Instantly...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance an...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...